Recent Insider Transactions - Taysha Gene Therapies (NASDAQ: TSHA) - Life Science Report

C4 Therapeutics

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ TSHA Taysha Gene Therapies

Nagendran Sukumar / director, officer: President and Head of R&D

08/21/2025

Sell

$2.85

57,054

$163K

1.17M

NASDAQ TSHA Taysha Gene Therapies

Alam Kamran / officer: CHIEF FINANCIAL OFFICER

08/21/2025

Sell

$2.85

54,491

$155K

1.19M

Research Tools

News & Announcements

Popular Topics

Miscellaneous